Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee

Jeanne Palmer, Jeannine S. McCune, Miguel Angel Perales, David Marks, Joseph Bubalo, Mohamad Mohty, John R. Wingard, Angelo Paci, Moustapha Hassan, Christopher Bredeson, Joseph Pidala, Nina Shah, Paul Shaughnessy, Navneet Majhail, Jeff Schriber, Bipin N. Savani, Paul A. Carpenter

    Research output: Contribution to journalReview article

    39 Citations (Scopus)

    Abstract

    The Practice Guidelines Committee of the American Society of Blood or Marrow Transplantation (ASBMT) sought to develop an evidence-based review about personalizing busulfan-based conditioning. The Committee sought to grade the relevant published studies (June 1, 2008 through March 31, 2016) according to criteria set forth by the Steering Committee for Evidence Based Reviews from ASBMT. Unfortunately, the published literature was too heterogeneous and lacked adequately powered and sufficiently controlled studies for this to be feasible. Despite this observation, the continued interest in this topic led the Practice Guidelines Committee to develop a list of most frequently asked questions (FAQs) regarding personalized busulfan dosing. This “Considerations” document is a list of these FAQs and their responses, addressing topics of practical relevance to hematopoietic cell transplantation clinicians.

    Original languageEnglish (US)
    Pages (from-to)1915-1925
    Number of pages11
    JournalBiology of Blood and Marrow Transplantation
    Volume22
    Issue number11
    DOIs
    StatePublished - Nov 1 2016

    Fingerprint

    Busulfan
    Practice Guidelines
    Transplantation
    Bone Marrow
    Cell Transplantation

    Keywords

    • Busulfan
    • Hematopoietic cell transplantation
    • Pharmacokinetics
    • Precision medicine
    • Therapeutic drug monitoring

    ASJC Scopus subject areas

    • Hematology
    • Transplantation

    Cite this

    Personalizing Busulfan-Based Conditioning : Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee. / Palmer, Jeanne; McCune, Jeannine S.; Perales, Miguel Angel; Marks, David; Bubalo, Joseph; Mohty, Mohamad; Wingard, John R.; Paci, Angelo; Hassan, Moustapha; Bredeson, Christopher; Pidala, Joseph; Shah, Nina; Shaughnessy, Paul; Majhail, Navneet; Schriber, Jeff; Savani, Bipin N.; Carpenter, Paul A.

    In: Biology of Blood and Marrow Transplantation, Vol. 22, No. 11, 01.11.2016, p. 1915-1925.

    Research output: Contribution to journalReview article

    Palmer, J, McCune, JS, Perales, MA, Marks, D, Bubalo, J, Mohty, M, Wingard, JR, Paci, A, Hassan, M, Bredeson, C, Pidala, J, Shah, N, Shaughnessy, P, Majhail, N, Schriber, J, Savani, BN & Carpenter, PA 2016, 'Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee', Biology of Blood and Marrow Transplantation, vol. 22, no. 11, pp. 1915-1925. https://doi.org/10.1016/j.bbmt.2016.07.013
    Palmer, Jeanne ; McCune, Jeannine S. ; Perales, Miguel Angel ; Marks, David ; Bubalo, Joseph ; Mohty, Mohamad ; Wingard, John R. ; Paci, Angelo ; Hassan, Moustapha ; Bredeson, Christopher ; Pidala, Joseph ; Shah, Nina ; Shaughnessy, Paul ; Majhail, Navneet ; Schriber, Jeff ; Savani, Bipin N. ; Carpenter, Paul A. / Personalizing Busulfan-Based Conditioning : Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee. In: Biology of Blood and Marrow Transplantation. 2016 ; Vol. 22, No. 11. pp. 1915-1925.
    @article{9a454bea8988419c89dda4d031009aab,
    title = "Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee",
    abstract = "The Practice Guidelines Committee of the American Society of Blood or Marrow Transplantation (ASBMT) sought to develop an evidence-based review about personalizing busulfan-based conditioning. The Committee sought to grade the relevant published studies (June 1, 2008 through March 31, 2016) according to criteria set forth by the Steering Committee for Evidence Based Reviews from ASBMT. Unfortunately, the published literature was too heterogeneous and lacked adequately powered and sufficiently controlled studies for this to be feasible. Despite this observation, the continued interest in this topic led the Practice Guidelines Committee to develop a list of most frequently asked questions (FAQs) regarding personalized busulfan dosing. This “Considerations” document is a list of these FAQs and their responses, addressing topics of practical relevance to hematopoietic cell transplantation clinicians.",
    keywords = "Busulfan, Hematopoietic cell transplantation, Pharmacokinetics, Precision medicine, Therapeutic drug monitoring",
    author = "Jeanne Palmer and McCune, {Jeannine S.} and Perales, {Miguel Angel} and David Marks and Joseph Bubalo and Mohamad Mohty and Wingard, {John R.} and Angelo Paci and Moustapha Hassan and Christopher Bredeson and Joseph Pidala and Nina Shah and Paul Shaughnessy and Navneet Majhail and Jeff Schriber and Savani, {Bipin N.} and Carpenter, {Paul A.}",
    year = "2016",
    month = "11",
    day = "1",
    doi = "10.1016/j.bbmt.2016.07.013",
    language = "English (US)",
    volume = "22",
    pages = "1915--1925",
    journal = "Biology of Blood and Marrow Transplantation",
    issn = "1083-8791",
    publisher = "Elsevier Inc.",
    number = "11",

    }

    TY - JOUR

    T1 - Personalizing Busulfan-Based Conditioning

    T2 - Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee

    AU - Palmer, Jeanne

    AU - McCune, Jeannine S.

    AU - Perales, Miguel Angel

    AU - Marks, David

    AU - Bubalo, Joseph

    AU - Mohty, Mohamad

    AU - Wingard, John R.

    AU - Paci, Angelo

    AU - Hassan, Moustapha

    AU - Bredeson, Christopher

    AU - Pidala, Joseph

    AU - Shah, Nina

    AU - Shaughnessy, Paul

    AU - Majhail, Navneet

    AU - Schriber, Jeff

    AU - Savani, Bipin N.

    AU - Carpenter, Paul A.

    PY - 2016/11/1

    Y1 - 2016/11/1

    N2 - The Practice Guidelines Committee of the American Society of Blood or Marrow Transplantation (ASBMT) sought to develop an evidence-based review about personalizing busulfan-based conditioning. The Committee sought to grade the relevant published studies (June 1, 2008 through March 31, 2016) according to criteria set forth by the Steering Committee for Evidence Based Reviews from ASBMT. Unfortunately, the published literature was too heterogeneous and lacked adequately powered and sufficiently controlled studies for this to be feasible. Despite this observation, the continued interest in this topic led the Practice Guidelines Committee to develop a list of most frequently asked questions (FAQs) regarding personalized busulfan dosing. This “Considerations” document is a list of these FAQs and their responses, addressing topics of practical relevance to hematopoietic cell transplantation clinicians.

    AB - The Practice Guidelines Committee of the American Society of Blood or Marrow Transplantation (ASBMT) sought to develop an evidence-based review about personalizing busulfan-based conditioning. The Committee sought to grade the relevant published studies (June 1, 2008 through March 31, 2016) according to criteria set forth by the Steering Committee for Evidence Based Reviews from ASBMT. Unfortunately, the published literature was too heterogeneous and lacked adequately powered and sufficiently controlled studies for this to be feasible. Despite this observation, the continued interest in this topic led the Practice Guidelines Committee to develop a list of most frequently asked questions (FAQs) regarding personalized busulfan dosing. This “Considerations” document is a list of these FAQs and their responses, addressing topics of practical relevance to hematopoietic cell transplantation clinicians.

    KW - Busulfan

    KW - Hematopoietic cell transplantation

    KW - Pharmacokinetics

    KW - Precision medicine

    KW - Therapeutic drug monitoring

    UR - http://www.scopus.com/inward/record.url?scp=84992346042&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84992346042&partnerID=8YFLogxK

    U2 - 10.1016/j.bbmt.2016.07.013

    DO - 10.1016/j.bbmt.2016.07.013

    M3 - Review article

    C2 - 27481448

    AN - SCOPUS:84992346042

    VL - 22

    SP - 1915

    EP - 1925

    JO - Biology of Blood and Marrow Transplantation

    JF - Biology of Blood and Marrow Transplantation

    SN - 1083-8791

    IS - 11

    ER -